154 related articles for article (PubMed ID: 30641908)
1. IL-1β Inflammatory Cytokine-Induced
Mendoza-Rodríguez MG; Ayala-Sumuano JT; García-Morales L; Zamudio-Meza H; Pérez-Yepez EA; Meza I
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641908
[TBL] [Abstract][Full Text] [Related]
2. IL-1β induced methylation of the estrogen receptor ERα gene correlates with EMT and chemoresistance in breast cancer cells.
Jiménez-Garduño AM; Mendoza-Rodríguez MG; Urrutia-Cabrera D; Domínguez-Robles MC; Pérez-Yépez EA; Ayala-Sumuano JT; Meza I
Biochem Biophys Res Commun; 2017 Aug; 490(3):780-785. PubMed ID: 28645612
[TBL] [Abstract][Full Text] [Related]
3. IL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells.
Mendoza-Rodríguez M; Arévalo Romero H; Fuentes-Pananá EM; Ayala-Sumuano JT; Meza I
Cancer Lett; 2017 Apr; 390():39-44. PubMed ID: 28093282
[TBL] [Abstract][Full Text] [Related]
4. CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β.
García-Morales L; Castillo AM; Tapia Ramírez J; Zamudio-Meza H; Domínguez-Robles MDC; Meza I
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244518
[TBL] [Abstract][Full Text] [Related]
5. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
6. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
8. A novel β-catenin signaling pathway activated by IL-1β leads to the onset of epithelial-mesenchymal transition in breast cancer cells.
Perez-Yepez EA; Ayala-Sumuano JT; Lezama R; Meza I
Cancer Lett; 2014 Nov; 354(1):164-71. PubMed ID: 25135221
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
[TBL] [Abstract][Full Text] [Related]
10. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
Zhu Y; Liu Y; Zhang C; Chu J; Wu Y; Li Y; Liu J; Li Q; Li S; Shi Q; Jin L; Zhao J; Yin D; Efroni S; Su F; Yao H; Song E; Liu Q
Nat Commun; 2018 Apr; 9(1):1595. PubMed ID: 29686231
[TBL] [Abstract][Full Text] [Related]
12. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
13. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer.
Wu HH; Wu JY; Cheng YW; Chen CY; Lee MC; Goan YG; Lee H
Clin Cancer Res; 2010 Nov; 16(21):5200-10. PubMed ID: 20959404
[TBL] [Abstract][Full Text] [Related]
14. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
17. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
